“Efficacy Outcomes in the Phase 3 COMBI-AD Study of Adjuvant Dabrafenib Plus Trametinib Vs Placebo in Patients With Stage III BRAFV600E K-Mutant Melanoma”. SKIN The Journal of Cutaneous Medicine 2, no. S1 (February 23, 2018): S43. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/291.